Guided Therapeutics, Inc. (GTHP)

Market Cap	8.48M
Revenue (ttm)	7.00K
Net Income (ttm)	-2.59M
Shares Out	77.97M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,500
Average Volume	19,151
Open	0.1000
Previous Close	0.1000
Day's Range	0.1000 - 0.1000
52-Week Range	0.0640 - 0.2300
Beta	0.41
RSI	56.29
Earnings Date	Mar 28, 2025

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is head...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: GTHP

Financial Performance

In 2024, Guided Therapeutics's revenue was $7,000, a decrease of -92.86% compared to the previous year's $98,000. Losses were -$2.59 million, -31.07% less than in 2023.